Soft Tissue Sarcoma Market Overview

Soft Tissues Sarcoma is the rare and diverse group of cancers that develop from tissues such as blood vessels, muscles, fats, nerves, and deep skin tissues etc. There are around 50 different types of soft tissue sarcoma that are identified, the common types of soft tissue sarcoma include liposarcomas, leiomyosarcomas, and others. The soft tissue sarcoma can be treated by the combined chemotherapy, radiotherapy, and surgery to remove the tumor. If surgical procedure is not required, chemotherapy can be used alone.

Some of the major driving factors includes increasing research and development on biological and targeted drug therapies for the cancer treatment along with the expiration of patents. The increasing healthcare expenditure for quality patient care and various advanced treatments also boost the growth of the global soft tissue sarcoma treatment market. In addition, increasing focus on personalized medicine along with huge investments for anti-cancer treatment research is likely to unveil new paths for soft tissue sarcoma treatment market in the near future.

The Global Soft Tissue Sarcoma Market  is expected to grow at a CAGR of approximately 8.90% during the forecast period 2017-2023.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/5304

Soft Tissue Sarcoma Market Segmentation

The soft tissue sarcoma is segmented on the basis of treatment, disease type, distribution channel, and end-users.

·         On the basis of the treatment type, the soft tissue sarcoma treatment market is segmented into targeted therapy, chemotherapy, anti-angiogenesis drugs, radiation therapy. Furthermore, the radiation therapy is subcategorized into internal radiation therapy and external radiation therapy.

·         On the basis of the disease type, soft tissue sarcoma treatment market is segmented into local sarcoma, regional sarcoma, and metastatic sarcoma.

·         On the basis of the distribution channel, soft tissue sarcoma treatment market is segmented into hospital pharmacies, retail pharmacies and other.

·         On the basis of the end user, the global soft tissue sarcoma treatment market has been segmented into hospitals, oncology centers, and long term care centers.

Soft Tissue Sarcoma Market Regional Analysis

Global soft tissue sarcoma consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Americas is expected to lead the global market due to high incidence of cancer and soft tissue sarcoma. According to the American Cancer Society, more than 11,400 new cases of soft tissue sarcoma were diagnosed in the U.S. in 2014. While, Europe is expected to hold the second largest market share in the global market. Market in Asia Pacific region is expected to witness significant growth owing to increasing case of cancer and growing awareness regarding advanced cancer treatments. In addition, increasing healthcare expenditure related to cancer and associated disease is expected to boost the market growth in near future.

Soft Tissue Sarcoma Market Players

·         Globus Medical, Inc. (U.S.)

·         Depuy Synthes Inc. (Johnson & Johnson) (U.S.)

·         Smith & Nephew plc. (UK)

·         NuVasive, Inc. (U.S.)

·         Stryker Corporation (U.S.)

·         Integra LifeSciences Holdings Corporation (U.S.)

·         Zimmer Biomet Holdings, Inc. (U.S.)

·         Medtronic, plc (Ireland)

·         Wright Medical Group N.V. (Netherlands)

·         The Orthopedic Implant Company (U.S.)

·         Aesculap Implant Systems (U.S.)

·         Conmed Corporation (U.S.)

·         BioTek Instruments, Inc. (U.S.)

·         Arthrocare Corporation (U.S.)

among others are some key companies in the global soft tissue sarcoma that are listed by MRFR for market research.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/soft-tissue-sarcoma-market-5304

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com